Related Experiment Videos
Intravitreal oxacillin in experimental staphylococcal endophthalmitis
Summary
Intravitreal oxacillin, combined with systemic treatment, proved more effective than subconjunctival oxacillin for experimental staphylococcal endophthalmitis. This approach achieved bactericidal concentrations in the vitreous, offering a promising treatment strategy.
Area of Science:
- Ophthalmology
- Infectious Diseases
- Pharmacology
Background:
- Staphylococcal endophthalmitis is a severe intraocular infection.
- Effective treatment requires achieving adequate antibiotic concentrations within the eye.
- Oxacillin is a key antibiotic for treating Staphylococcus aureus infections.
Purpose of the Study:
- To compare the efficacy of combined intravitreal and systemic oxacillin versus combined subconjunctival and systemic oxacillin.
- To evaluate the safety and intraocular penetration of intravitreal oxacillin.
- To determine optimal timing for treatment initiation in experimental endophthalmitis.
Main Methods:
- Experimental model of Staphylococcus aureus endophthalmitis in eyes.
- Administration of oxacillin via intravitreal, subconjunctival, and intramuscular routes.
- Assessment of intraocular toxicity and vitreous antibiotic concentrations.
- Evaluation of treatment outcomes at 8, 10, and 12 hours post-inoculation.
Main Results:
- Intravitreal injection of 500 mcg oxacillin was well-tolerated and achieved bactericidal vitreous concentrations for nearly 24 hours.
- Combined intravitreal oxacillin and systemic oxacillin demonstrated superior efficacy compared to combined subconjunctival oxacillin and systemic oxacillin.
- Treatment was effective even when initiated 8-12 hours after bacterial inoculation.
Conclusions:
- Intravitreal oxacillin is a safe and effective method for delivering bactericidal concentrations of the antibiotic into the vitreous.
- Combined intravitreal and systemic oxacillin represents a superior therapeutic strategy for experimental staphylococcal endophthalmitis compared to subconjunctival administration.
- Early intervention with intravitreal oxacillin offers a promising approach to managing this serious ocular infection.